Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing

Nutriband is keeping its NTRBW warrant terms unchanged as the September 30, 2026 expiration approaches, with a $6.43 strike price.

Rhea-AI Summary

Nutriband (NTRB) confirmed that its outstanding Nasdaq-listed warrants (NTRBW) will expire as scheduled on September 30, 2026 at 5PM ET, with no extension or repricing.

Warrant holders may exercise at a strike price of $6.43 per share until the deadline. There are 910,904 warrants outstanding, representing potential proceeds of $5,856,112 to the company if fully exercised. Warrants not exercised by the expiration time will lapse in full and be removed from the NTRBW Nasdaq listing. The company advises shareholders and warrant holders to act before the deadline if they intend to exercise.

Positive

• Outstanding NTRBW warrants could yield $5,856,112 in proceeds if fully exercised at $6.43
• Clear confirmation of no extension or repricing removes uncertainty around warrant terms

Negative

• All 910,904 NTRBW warrants will expire September 30, 2026 if not exercised
• Expired warrants will be removed from the NTRBW Nasdaq listing after lapse

Market Context

A February 12 424B3 filing also reported 910,904 warrants exercisable at $6.43, directly corroborati...

Analysis

A February 12 424B3 filing also reported 910,904 warrants exercisable at $6.43, directly corroborating the warrant pool and exercise terms addressed in this expiration notice.

Key Figures

Warrant expiration: September 30, 2026 at 5PM ET Strike price: $6.43 per share Warrants outstanding: 910,904 warrants +1 more

Warrant expiration

September 30, 2026 at 5PM ET

Scheduled expiration deadline

Strike price

$6.43 per share

Current warrant exercise price

Warrants outstanding

910,904 warrants

Outstanding warrants subject to expiration

Potential proceeds

$5,856,112

Potential company proceeds if all warrants are exercised

Key Terms

warrants, strike price, repricing

3 terms

warrants financial

"The Company will not extend the expiration date and will not reprice the warrants."

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

View in glossary

strike price financial

"Warrant holders may exercise at the current strike price of $6.43 per share"

The strike price is the fixed price at which an option gives its holder the right to buy or sell an underlying stock. Think of it like a coupon that lets you transact at a pre-agreed price regardless of the market; for investors it determines whether an option will be profitable, influences potential gains or losses, and is a key factor in the option’s market value and risk profile.

View in glossary

repricing financial

"The Company will not extend the expiration date and will not reprice the warrants."

Repricing is the act of changing the stated price associated with a financial instrument or contract, such as lowering the exercise price of employee stock options, adjusting the coupon or yield on a bond, or formally setting a new listed price for a security. It matters to investors because it alters the economic terms and potential value of holdings or claims—like changing the label on a product so buyers and sellers face a different cost or payoff.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ORLANDO, Fla., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) confirmed today that its outstanding warrants (NASDAQ:NTRBW) will expire on September 30, 2026 at 5PM ET as scheduled. The Company will not extend the expiration date and will not reprice the warrants.

Warrant holders may exercise at the current strike price of $6.43 per share until the expiration date. Warrants not exercised by that date will expire in their entirety and be removed from the NTRBW Nasdaq listing.

There are currently 910,904 warrants outstanding, representing $5,856,112 in potential proceeds to the Company if fully exercised at the $6.43 strike price.

Key dates and terms:

• Expiration date: September 30, 2026 5PM ET
• Strike price: $6.43 per warrant
• Warrants outstanding: 910,904
• No extension. No repricing.

Shareholders and warrant holders are advised to act before the deadline if they intend to exercise. Nutriband will continue to provide updates on Company developments in the coming weeks.

About Nutriband Inc.

We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse deterrent fentanyl patch incorporating our AVERSA™ abuse deterrence technology. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

The Company's website is www.nutriband.com. Any material contained in or derived from the Company's websites or any other website is not part of this press release.

Forward-Looking Statements

Certain statements contained in this press release, including, without limitation, statements containing the words “believes,” “anticipates,” “expects” and words of similar import, constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. The Company's actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including those including the Company's ability to develop its proposed abuse-deterrent fentanyl transdermal system and other proposed products, its ability to obtain patent protection for its abuse technology, its ability to obtain the necessary financing to develop products and conduct the necessary clinical testing, its ability to obtain Federal Food and Drug Administration approval to market any product it may develop in the United States and to obtain any other regulatory approval necessary to market any product in other countries, including countries in Europe, its ability to market any product it may develop, its ability to create, sustain, manage or forecast its growth; its ability to attract and retain key personnel; changes in the Company's business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions and risks generally associated with an undercapitalized developing company, as well as the risks contained under “Risk Factors” and “Management's Discussion and Analysis of Financial Condition and Results of Operations” in the Company's periodic and current reports on Form 10-K, Forms 10-Q and 8-K and the Company's other filings with the Securities and Exchange Commission. Except as required by applicable law, we undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof.

Contact Information:
Nutriband Inc.
Phone: 407-377-6695
Email: info@nutriband.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the key terms and deadline for exercising Nutriband NTRBW warrants?

Each NTRBW warrant can be exercised at a strike price of $6.43 per share until September 30, 2026 at 5PM ET. The company has stated there will be no extension of the expiration date and no repricing of the warrants.

What happens to NTRBW warrants that are not exercised by the expiration time?

Warrants that are not exercised by 5PM ET on September 30, 2026 will expire in their entirety and will be removed from the NTRBW Nasdaq listing.

How many Nutriband warrants are currently outstanding and what is their potential value to the company?

There are currently 910,904 NTRBW warrants outstanding. If all of these warrants are exercised at the $6.43 strike price, they represent $5,856,112 in potential proceeds to Nutriband.